Nick Damiano
CEO & Co-Founder
Nick Damiano is an accomplished medical technology executive and entrepreneur with a proven track record of founding and leading innovative healthcare startups. As the CEO and Co-Founder of Andromeda Surgical, he leverages his deep industry expertise and technical acumen to drive the company's vision of revolutionizing surgical procedures through cutting-edge medical devices.
Professional Overview
With over 15 years of experience in the medtech sector, Nick has a strong background in product development, strategic business planning, and venture capital investing. He is recognized for his ability to identify unmet clinical needs, transform innovative ideas into viable commercial products, and build high-performing teams to execute on ambitious growth plans.
Experience Summary
Current Role
As the CEO and Co-Founder of Andromeda Surgical, Nick is responsible for setting the strategic direction of the company, overseeing all operations, and fostering a culture of innovation and collaboration. Under his leadership, Andromeda Surgical has rapidly gained traction in the market, securing key partnerships and securing $25 million in Series A funding to accelerate the development and commercialization of its groundbreaking surgical devices.
In addition to his role at Andromeda Surgical, Nick also serves as a Venture Partner at Pioneer Fund, where he leverages his deep industry expertise and networks to identify and support promising medtech startups.
Career Progression
Prior to co-founding Andromeda Surgical, Nick held several leadership positions in the medtech industry. He was the Founder and CEO of Zenflow, Inc., a venture-backed startup focused on developing minimally invasive solutions for benign prostatic hyperplasia (BPH). Under his guidance, Zenflow secured over $50 million in funding and achieved significant milestones in product development and clinical trials.
Nick also served as the Chief Strategy Officer at APstem Therapeutics, where he played a pivotal role in shaping the company's strategic vision and driving its growth in the regenerative medicine space. Earlier in his career, he co-founded Avail Medsystems, a pioneering telehealth platform for remote surgical procedures, and held engineering roles at Webgen, Inc. and Kensey Nash Corporation.
Academic Background
Nick holds a Bachelor of Science in Biomedical Engineering from Washington University in St. Louis, where he graduated with high distinction and was recognized for his academic excellence.
Areas of Expertise
- Medical device and product development
- Startup founding and scaling
- Venture capital investing and portfolio management
- Strategic business planning and execution
- Cross-functional team leadership and collaboration
Professional Impact
Throughout his career, Nick has demonstrated a remarkable ability to translate innovative ideas into successful commercial ventures. His leadership and technical expertise have been instrumental in the development and commercialization of several groundbreaking medical technologies, positively impacting patient outcomes and advancing the frontiers of the medtech industry.
Conclusion
As a seasoned medtech entrepreneur and investor, Nick Damiano is poised to continue his trajectory of driving transformative change in the healthcare sector. With his unwavering commitment to innovation, strategic vision, and collaborative approach, he is well-equipped to guide Andromeda Surgical and its portfolio of cutting-edge surgical solutions to new heights of success.
